journal article·2023-10-18Open access

Preparation of Self-Assembled, Curcumin-Loaded Nano-Micelles Using Quarternized Chitosan–Vanillin Imine (QCS-Vani Imine) Conjugate and Evaluation of Synergistic Anticancer Effect with Cisplatin

Sasikarn Sripetthong, Sirinporn Nalinbenjapun, Abdul Basit, Suvimol Surassmo, Warayuth Sajomsang, Chitchamai Ovatlarnporn

Journal of Functional Biomaterials· Volume 14· Issue 10

Abstract

Nano-micelles are self-assembling colloidal dispersions applied to enhance the anticancer efficacy of chemotherapeutic agents. In this study, the conjugate of quarternized chitosan and vanillin imine (QCS-Vani imine) was synthesized using the reaction of a Schiff base characterized by proton-NMR (1HNMR), UV-Vis spectroscopy, and FT-IR. The critical micelle concentration (CMC), particle size, and zeta potential of the resulting product were determined. The QCS-Vani imine conjugate was used as a carrier for the development of curcumin-loaded nano-micelles, and their entrapment efficiency (%EE), drug-loading capacity (%LC) and in vitro release were investigated using HPLC analysis. Moreover, the nano-micelles containing curcumin were combined with various concentrations of cisplatin and evaluated for a possible anticancer synergistic effect. The anticancer activity was evaluated against lung cancer A549 and mouse fibroblast L929 cell lines. The percent yield (%) of the QCS-Vani imine conjugate was 93.18%. The curcumin-loaded QCS-Vani imine nano-micelles were characterized and found to have a spherical shape (by TEM) with size < 200 nm (by DLS) with high %EE up to 67.61% and %LC up to 6.15 ± 0.41%. The loaded lyophilized powder of the nano-micelles was more stable at 4 °C than at room temperature during 120 days of storage. pH-sensitive release properties were observed to have a higher curcumin release at pH 5.5 (cancer environment) than at pH 7.4 (systemic environment). Curcumin-loaded QCS-Vani imine nano-micelles showed higher cytotoxicity and selectivity toward lung cancer A549 cell lines and exhibited lower toxicity toward the normal cell (H9C2) than pure curcumin. Moreover, the curcumin-loaded QCS-Vani imine nano-micelles exhibited an enhanced property of inducing cell cycle arrest during the S-phase against A549 cells and showed prominently induced apoptosis in lung cancer cells compared to that with curcumin. The co-treatment of cisplatin with curcumin-loaded QCS-Vani imine nano-micelles presented an enhanced anticancer effect, showing 8.66 ± 0.88 μM as the IC50 value, in comparison to the treatment with cisplatin alone (14.22 ± 1.01 μM). These findings suggest that the developed QCS-Vani imine nano-micelle is a potential drug delivery system and could be a promising approach for treating lung cancer in combination with cisplatin.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Curcumin's Biomedical Applications · Free Radicals and Antioxidants · Phytochemicals and Antioxidant Activities

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat Yai 90112, Thailand

Drug Delivery System Excellent Center, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat Yai 90112, Thailand

Nano-Delivery System Laboratory, National Nanotechnology Center, National Science and Technology Development Agency, Thailand Science Park, Pathum Thani 12120, Thailand

Funding

National Science, Research and Innovation Fund (NSRF) · Thailand Graduate Institute of Science and Technology Scholarship · Graduate School Prince of Songkla University

References (55)

Show source-provided references
1. Riudavets, M., de Herreros, M.G., Besse, B., and Mezquita, L. (2022). Radon and lung cancer: Current trends and future perspectives. Cancers, 14.10.3390/cancers14133142 ↗
2. Co-delivery of doxorubicin and curcumin via cRGD-peptide modified PEG-PLA self-assembly nanomicelles for lung cancer therapy10.1016/j.cclet.2021.11.076 ↗
3. Global epidemiology of lung cancer10.5334/aogh.2419 ↗
4. US National Cancer Institute (2022, October 11). Cancer Stat Facts: Lung and Bronchus Cancer, Available online: https://seer.cancer.gov/statfacts/html/lungb.html.
5. Cancer statistics, 201910.3322/caac.21551 ↗
6. Clinical Decision Support for Symptom Management in Lung Cancer Patients: A Group RCT10.1016/j.jpainsymman.2021.12.006 ↗
7. Advances in our understanding of the molecular mechanisms of action of cisplatin in cancer therapy10.2147/JEP.S267383 ↗
8. Curcumin and lung cancer–A review10.1007/s11523-014-0321-1 ↗
9. Versatile role of curcumin and its derivatives in lung cancer therapy10.1002/jcp.29819 ↗
10. Curcumin: Updated molecular mechanisms and intervention targets in human lung cancer10.3390/ijms13033959 ↗
11. Induction of apoptosis in human lung cancer cells by curcumin10.1016/j.canlet.2004.01.008 ↗
12. Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ110.1158/0008-5472.CAN-07-6734 ↗
13. Yang, Z.-J., Huang, S.-Y., Zhou, D.-D., Xiong, R.-G., Zhao, C.-N., Fang, A.-P., Zhang, Y.-J., Li, H.-B., and Zhu, H.-L. (2022). Effects and mechanisms of curcumin for the prevention and management of cancers: An updated review. Antioxidants, 11.10.3390/antiox11081481 ↗
14. Effect of nano-curcumin on various diseases: A comprehensive review of clinical trials10.1002/biof.1932 ↗
15. Curcumin and lung cancer: The role of microRNAs10.2174/1381612823666170109144818 ↗
16. Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and-9 and Vascular Endothelial Growth Factor (VEGF)10.1016/j.canlet.2009.04.037 ↗
17. Khan, F.B., Singh, P., Jamous, Y.F., Ali, S.A., Uddin, S., Zia, Q., Jena, M.K., Khan, M., Owais, M., and Huang, C.Y. (2023). Multifaceted Pharmacological Potentials of Curcumin, Genistein, and Tanshinone IIA through Proteomic Approaches: An In-Depth Review. Cancers, 15.10.3390/cancers15010249 ↗
18. Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects10.1002/ptr.7305 ↗
19. A difunctional Pluronic® 127-based in situ formed injectable thermogels as prolonged and controlled curcumin depot, fabrication, in vitro characterization and in vivo safety evaluation10.1080/09205063.2020.1829324 ↗
20. Innovative preparation of curcumin for improved oral bioavailability10.1248/bpb.34.660 ↗
21. Tabanelli, R., Brogi, S., and Calderone, V. (2021). Improving curcumin bioavailability: Current strategies and future perspectives. Pharmaceutics, 13.10.3390/pharmaceutics13101715 ↗
22. Pharmaceutical strategies of improving oral systemic bioavailability of curcumin for clinical application10.1016/j.jconrel.2019.10.053 ↗
23. Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin10.1517/17425247.2012.724676 ↗
24. Enhancing curcumin oral bioavailability through nanoformulations10.1007/s13318-019-00545-z ↗
25. Application of functional biocompatible nanomaterials to improve curcumin bioavailability10.3389/fchem.2020.589957 ↗
26. Nanomicelles: Types, properties and applications in drug delivery10.1049/nbt2.12018 ↗
27. Synthesis and characterization of chitosan derivatives with dual-antibacterial functional groups10.1016/j.ijbiomac.2015.01.056 ↗
28. Preparation and characterization of vanillin-chitosan Schiff base zinc complex for a novel Zn2+ sustained released system10.1016/j.ijbiomac.2021.11.104 ↗
29. Simultaneous determination of degree of deacetylation, degree of substitution and distribution fraction of–COONa in carboxymethyl chitosan by potentiometric titration10.1016/j.carbpol.2011.12.019 ↗
30. Quercetin/chitosan-graft-alpha lipoic acid micelles: A versatile antioxidant water dispersion with high stability10.1016/j.carbpol.2020.115927 ↗
31. Multifunctional quercetin conjugated chitosan nano-micelles with P-gp inhibition and permeation enhancement of anticancer drug10.1016/j.carbpol.2018.09.020 ↗
32. Fabrication of Redox-and pH-Sensitive Self-Assembled Nano-Micelles with Pegylated β-Cyclodextrin for Codelivery of Doxorubicin and Cyclopalladated Ferrocene10.1002/ejic.202101061 ↗
33. Determination of the critical micelle concentration of surfactants using fluorescence strategies10.1039/D2SM01320G ↗
34. Sripetthong, S., Eze, F.N., Sajomsang, W., and Ovatlarnporn, C. (2023). Development of pH-Responsive N-benzyl-N-O-succinyl Chitosan Micelles Loaded with a Curcumin Analog (Cyqualone) for Treatment of Colon Cancer. Molecules, 28.10.3390/molecules28062693 ↗
35. Formulation and evaluation of mixed polymeric micelles of quercetin for treatment of breast, ovarian, and multidrug resistant cancers10.2147/IJN.S153094 ↗
36. Chemosensitizing effects of synthetic curcumin analogs on human multi-drug resistance leukemic cells10.1016/j.cbi.2015.12.001 ↗
37. New chitosan polymer scaffold Schiff bases as potential cytotoxic activity: Synthesis, molecular docking, and physiochemical characterization10.3389/fchem.2021.796599 ↗
38. Curcumin drug delivery by vanillin-chitosan coated with calcium ferrite hybrid nanoparticles as carrier10.1016/j.ejps.2018.01.023 ↗
39. Vanillin crosslinked chitosan films: The states of water and the effect of carriers on curcumin uptake10.1016/j.carbpol.2022.119725 ↗
40. Chitosan oligosaccharide-based dual pH responsive nano-micelles for targeted delivery of hydrophobic drugs10.1016/j.carbpol.2019.115061 ↗
41. Preparation and characterization of vanillin-conjugated chitosan-stabilized emulsions via a Schiff-base reaction10.1007/s10068-023-01277-2 ↗
42. pH responsive release of paclitaxel by self-assembling Chitosan-ethyl vanillin@ GNRs nanocomposites10.1016/j.ijpharm.2021.121047 ↗
43. Preparation, characterization and antioxidant properties of curcumin encapsulated chitosan/lignosulfonate micelles10.1016/j.carbpol.2021.119080 ↗
44. Nano-micelles based on hydroxyethyl starch-curcumin conjugates for improved stability, antioxidant and anticancer activity of curcumin10.1016/j.carbpol.2019.115398 ↗
45. Moniruzzaman, M., and Min, T. (2020). Curcumin, curcumin nanoparticles and curcumin nanospheres: A review on their pharmacodynamics based on monogastric farm animal, poultry and fish nutrition. Pharmaceutics, 12.10.3390/pharmaceutics12050447 ↗
46. In vivo efficacy and toxicity of curcumin nanoparticles in breast cancer treatment: A systematic review10.3389/fonc.2021.612903 ↗
47. Quaternization of high molecular weight chitosan for increasing intestinal drug absorption using Caco-2 cells as an in vitro intestinal model10.1038/s41598-023-34888-0 ↗
48. Curcumin encapsulation in self-assembled nanoparticles based on amphiphilic palmitic acid-grafted-quaternized chitosan with enhanced cytotoxic, antimicrobial and antioxidant properties10.1016/j.ijbiomac.2022.10.064 ↗
49. Curcumin and its derivatives in breast cancer: Current developments and potential for the treatment of drug-resistant cancers10.7243/2052-6199-1-6 ↗
50. Potential of amphiphilic graft copolymer α-tocopherol succinate-g-carboxymethyl chitosan in modulating the permeability and anticancer efficacy of tamoxifen10.1016/j.ejps.2017.02.023 ↗
51. Understanding apoptosis and apoptotic pathways targeted cancer therapeutics10.15171/apb.2019.024 ↗
52. Molecular targeting: New therapeutic strategies to improve tumour apoptosis10.1093/annonc/mdh931 ↗
53. Apoptosis as a goal of cancer therapy10.1097/00001622-199411000-00015 ↗
54. Natural product target network reveals potential for cancer combination therapies10.3389/fphar.2019.00557 ↗
55. Curcumin reverses cisplatin resistance in cisplatin-resistant lung caner cells by inhibiting FA/BRCA pathway10.1007/s13277-014-2996-4 ↗